Cumberland Pharmaceuticals, Inc. (CPIX)
7.39
-0.12
(-1.60%)
USD |
NASDAQ |
Oct 02, 16:00
7.39
0.00 (0.00%)
After-Hours: 20:00
Cumberland Pharmaceuticals Net Income (Quarterly) : -3.104M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.104M |
| March 31, 2026 | -3.287M |
| December 31, 2025 | -1.429M |
| September 30, 2025 | -1.949M |
| June 30, 2025 | -2.998M |
| March 31, 2025 | 1.248M |
| December 31, 2024 | -1.902M |
| September 30, 2024 | -1.537M |
| June 30, 2024 | -1.103M |
| March 31, 2024 | -1.902M |
| December 31, 2023 | -6.302M |
| September 30, 2023 | -1.063M |
| June 30, 2023 | 0.8622M |
| March 31, 2023 | 0.1723M |
| December 31, 2022 | -2.460M |
| September 30, 2022 | -0.4232M |
| June 30, 2022 | -1.365M |
| March 31, 2022 | -1.402M |
| December 31, 2021 | -4.388M |
| September 30, 2021 | -1.584M |
| June 30, 2021 | 0.7247M |
| March 31, 2021 | -0.3507M |
| December 31, 2020 | -1.788M |
| September 30, 2020 | -1.276M |
| June 30, 2020 | -1.679M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.883M |
| December 31, 2019 | -3.369M |
| September 30, 2019 | -3.316M |
| June 30, 2019 | -1.338M |
| March 31, 2019 | -1.188M |
| December 31, 2018 | -2.237M |
| September 30, 2018 | -1.664M |
| June 30, 2018 | -0.7454M |
| March 31, 2018 | -2.392M |
| December 31, 2017 | -0.8218M |
| September 30, 2017 | -0.7572M |
| June 30, 2017 | -5.177M |
| March 31, 2017 | -1.294M |
| December 31, 2016 | -0.7699M |
| September 30, 2016 | 0.0955M |
| June 30, 2016 | -0.0609M |
| March 31, 2016 | -0.2686M |
| December 31, 2015 | 0.1286M |
| September 30, 2015 | 0.1217M |
| June 30, 2015 | 0.3943M |
| March 31, 2015 | 0.0265M |
| December 31, 2014 | 0.6486M |
| September 30, 2014 | 0.7292M |
| June 30, 2014 | 0.7095M |
| March 31, 2014 | 0.2752M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.1665M |
| Total Expenses (Quarterly) | 3.273M |
| EPS Diluted (Quarterly) | -0.2854 |
| Enterprise Value | 111.25M |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -9.87% |
| Normalized Earnings Yield | -9.636 |